Anteris Technologies Global Corp

Anteris Technologies Global Corp

AVR · AU · Healthcare / Medical Devices

8.65AUD-0.35 (-3.89%)

Price History

Full chart

Market Stats

Previous Close9.00
Open8.80
Day Range8.65 – 8.80
52-Week Range5.20 – 15.47
Volume3.38K
Market Cap1.08B
P/E (TTM)0.00
Forward P/E0.00
EPS-2.81
Dividend Yield0.00%
Beta0.73
50-Day Avg11.79
200-Day Avg10.24

About

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Wayne Geoffrey Paterson
  • Employees174
  • HeadquartersToowong Tower, Toowong, QLD, Australia, 4066, Australia
  • Websitehttps://anteristech.com

Leadership

  • Mr. Wayne Geoffrey PatersonVice Chairman & CEO · b. 1967
  • Mr. David St. DenisPresident & Director · b. 1969
  • Mr. Matthew McDonnellHead of Australia · b. 1973
  • Mr. Brent A. MoenChief Financial Officer · b. 1967
  • Dr. Chris Meduri M.D., M.P.H.Chief Medical Officer & Member of Medical Advisory Board

Financials

Income Statement

Currency: USD2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-------6.75M6.44M7.40M7.90M10.13M14.15M22.32M22.61M25.60M17.08M7.08M7.79M4.59M4.11M2.70M1.91M
Growth (%)---------4.65%+15.03%+6.71%+28.27%+39.64%+57.76%+1.28%+13.23%-33.30%-58.54%+10.06%-41.08%-10.43%-34.25%-29.23%
Cost of Revenue53.66K95.27K-----3.76M3.39M3.76M13.65M7.35M9.03M28.29M9.27M13.35M30.97M15.28M16.60M26.17M4.54M1.44M569.00K
Gross Profit-53.66K-95.27K-----2.99M3.05M3.64M-5.75M2.78M5.12M-5.97M13.34M12.44M-13.90M-8.20M-8.81M-21.58M-423.23K1.27M1.34M
Gross Margin-------44.32%47.37%49.23%-72.72%27.44%36.20%-26.75%58.99%48.59%-81.39%-115.85%-113.11%-470.21%-10.29%46.84%70.26%
Operating Expense661.69K814.48K-----4.10M7.05M7.81M8.01M22.01M28.81M7.28M27.67M35.70M11.81M10.78M14.20M25.80M70.95M79.64M95.24M
Operating Income-715.35K-909.75K-1.11M-1.60M-1.46M-1.31M-1.49M-1.11M-4.00M-4.16M-13.76M-19.23M-23.69M-13.25M-14.34M-23.26M-25.71M-18.98M-23.01M-47.39M-71.37M-78.37M-93.89M
Operating Margin--------16.41%-62.12%-56.21%-174.18%-189.80%-167.39%-59.36%-63.41%-90.87%-150.55%-268.08%-295.31%-1032.36%-1736.07%-2899.45%-4908.21%
EBITDA-639.45K-1.89M-1.17M-2.79M-1.48M-1.28M-1.44M-1.75M-3.64M-1.59M-13.18M-22.88M-27.81M-14.07M-15.89M-22.05M-4.06M-15.64M-21.42M-43.03M-66.90M-69.39M-92.49M
EBITDA Margin--------25.94%-56.61%-21.46%-166.81%-225.78%-196.50%-63.01%-70.27%-86.12%-23.77%-220.97%-274.97%-937.56%-1627.41%-2567.08%-4834.87%
Net Income-650.35K-1.77M-1.11M-2.09M-1.13M-1.02M-1.17M-1.95M-10.00M-1.89M-6.62M-25.25M-24.01M-12.31M-17.26M-24.22M-5.82M-15.27M-22.91M-44.34M-67.33M-76.29M-94.14M
Net Income Margin--------28.93%-155.31%-25.56%-83.75%-249.21%-169.70%-55.15%-76.35%-94.59%-34.08%-215.78%-294.02%-966.01%-1637.85%-2822.46%-4921.28%
R&D-21.00K240.64K233.22K16.45K17.96K37.10K-393.72K811.05K1.89M2.55M4.81M1.76M1.20M3.37M3.32M4.63M8.01M13.21M46.54M51.45M69.12M
R&D as % of Total Revenue--------6.12%10.96%23.86%25.12%33.97%7.87%5.29%13.18%19.42%65.47%102.84%287.89%1132.00%1903.48%3613.17%
Interest Expense6.82K3.74M02.37M55.68K84.39K155.54K000072.22K73.51K59.78K331.24K2.64M505.57K574.94K1.50M935.78K101.07K29.09K73.00K
Interest Expense % of Total Revenue-------0.00%0.00%0.00%0.00%0.71%0.52%0.27%1.47%10.31%2.96%8.12%19.31%20.39%2.46%1.08%3.82%

Balance Sheet

Currency: USD2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets5.07M3.83M3.92M2.58M1.56M1.30M1.40M14.75M11.20M16.56M39.76M41.26M26.78M28.58M28.37M31.86M26.00M12.65M29.48M23.48M45.70M80.70M23.00M
Total Liabilities55.50K21.61K551.37K245.06K175.36K203.17K158.94K1.11M764.26K1.49M2.59M2.70M4.14M4.61M13.44M10.38M10.47M10.24M15.13M10.26M17.04M18.02M23.25M
Total Equity5.01M3.81M2.79M2.01M1.20M1.03M1.21M13.64M10.43M13.25M35.31M36.23M20.75M22.93M14.08M21.12M15.54M2.41M14.35M13.22M28.60M62.76M-93.00K
Cash3.72M3.36M2.75M2.15M1.45M1.25M1.35M1.35M2.06M2.45M19.58M24.03M8.81M11.26M8.25M12.04M8.97M4.35M21.30M13.81M30.83M70.46M12.58M
Total Debt--30.68K20.01K20.01K20.01K20.01K20.05K20.01K-----4.77M-3.62M4.72M6.94M2.79M2.34M1.40M2.28M
Net Debt-3.72M-3.36M-2.71M-2.13M-1.43M-1.23M-1.33M-1.33M-2.04M-2.45M-19.58M-24.03M-8.81M-11.26M-3.49M-12.04M-6.35M-571.40K-15.57M-12.40M-28.49M-69.06M-10.29M

Cash Flow

Currency: USD2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-583.85K-720.48K-534.48K-1.51M-921.64K-994.45K-1.24M-1.47M-3.54M-3.70M-10.64M-21.50M-21.94M-12.47M-13.25M-22.21M-22.87M-14.37M-18.81M-39.00M-51.43M-61.24M-77.80M
Investing Cash Flow-1.10M-196.13K-82.27K-105.14K-63.52K-45.35K-33.91K-308.14K-2.46M-770.33K-271.09K-689.84K-385.87K-2.67M-2.29M-1.01M20.57M7.76M-1.16M-1.36M-3.90M-2.14M-596.00K
Financing Cash Flow5.65M560.47K-1.01M286.81K840.82K1.37M3.27M6.71M4.85M28.05M26.63M7.12M17.11M9.01M27.15M8.73K1.89M36.91M31.36M72.95M105.88M20.55M
Capital Expenditure1.35M196.13K83.65K105.14K63.52K45.67K33.91K96.52K92.96K92.94K368.19K433.63K279.72K268.94K1.56M611.22K67.16K288.52K772.66K2.41M3.56M2.27M1.95M
Free Cash Flow-1.94M-916.61K-618.13K-1.61M-985.15K-1.04M-1.27M-1.57M-3.63M-3.79M-11.01M-21.93M-22.22M-12.74M-14.82M-22.82M-22.93M-14.66M-19.58M-41.40M-55.00M-63.51M-79.76M
Dividends Paid---26.58K--------0---649.16K-5.00M30.61M---
FCF to OCF331.59%127.22%115.65%106.98%106.89%104.59%102.74%106.56%102.63%102.51%103.46%102.02%101.27%102.16%111.80%102.75%100.29%102.01%104.11%106.18%106.93%103.70%102.51%
Dividend Paid to FCF----1.65%--------0.00%----2.83%--25.53%-73.93%---

Earnings

Report DateAug 28, 2014Feb 26, 2016Aug 29, 2016Oct 27, 2016Feb 24, 2017Apr 25, 2017Jul 25, 2017Feb 27, 2018Apr 27, 2018Aug 27, 2018Oct 24, 2018Feb 28, 2019Apr 26, 2019Aug 23, 2019Oct 23, 2019Feb 28, 2020May 1, 2020Aug 21, 2020Oct 28, 2020Feb 18, 2021Apr 30, 2021Aug 26, 2021Oct 27, 2021Feb 25, 2022Apr 29, 2022Aug 24, 2022Oct 26, 2022Feb 28, 2023Apr 14, 2023Aug 25, 2023Oct 31, 2023Jan 31, 2024Apr 26, 2024Aug 22, 2024Nov 18, 2024Mar 12, 2025May 13, 2025Aug 11, 2025Nov 12, 2025Feb 26, 2026
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00-----0.87-0.87-0.73-0.75
EPS Actual0.00-0.07-0.060.00-0.030.00-0.02-0.03-0.02-0.030.00-0.040.00-0.020.000.970.00-1.010.00-1.570.00-1.580.00-1.520.00-1.730.00-1.59-0.43-0.44-0.45-0.61-0.69-0.79-0.91-1.33-0.94-0.89-0.95-1.06
Surprise-------------------------------------8.05%-2.30%-30.14%-41.33%
Timing-----------------------Pre-market--After-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-market----After-hoursAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap1.08B
Enterprise Value687.71M
Trailing P/E0.00
Forward P/E0.00
Price / Sales481.94
Price / Book2.96
EPS-2.81
Book Value3.63
Revenue (TTM)2.24M
Gross Profit (TTM)1.68M
EBITDA-104.50M
Profit Margin0.00%
Operating Margin-3072.05%
Return on Equity-74.65%
Return on Assets-42.51%
Shares Outstanding97.34M
Shares Float65.98M
Beta0.73
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20071×
0.06Mar 2, 2007
20062×
0.05Sep 8, 20060.04Mar 1, 2006
20052×
0.04Oct 6, 20050.03Mar 16, 2005
20041×
0.01Nov 5, 2004

Stock Splits

  • Mar 2, 20201:100
  • Nov 17, 20151:10
  • Mar 24, 201564:63
  • Sep 25, 2013474:445
  • Feb 19, 200963:52